文献速递腹部胸部技术与安全CT

CT体成分测量预测胃食管腺癌新辅助治疗耐受性与生存

CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2022-10-09

该回顾性研究纳入142例接受新辅助治疗的胃食管腺癌患者,利用深度学习在L3椎体水平测量骨骼肌、内脏脂肪和皮下脂肪面积。多因素分析显示骨骼肌面积、内脏脂肪面积及骨骼肌指数与治疗耐受性相关,高骨骼肌指数与BMI与生存改善相关,基于BMI、SMI、年龄、性别和分期的Cox模型可区分高风险组(HR=1.77)。

要点

  • L3水平骨骼肌面积和骨骼肌指数(SMI)与治疗耐受性和生存相关。
  • BMI升高和SMI升高与生存改善相关。
  • 基于BMI、SMI、年龄、性别和分期的模型可识别生存较差的高风险患者。

局限性

  • 单中心回顾性研究
  • 样本量有限(142例)

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Treatment for gastroesophageal adenocarcinomas can result in significant morbidity and mortality. The purpose of this study is to supplement methods for choosing treatment strategy by assessing the relationship between CT-derived body composition, patient, and tumor features, and clinical outcomes in this population.

METHODS: Patients with neoadjuvant treatment, biopsy-proven gastroesophageal adenocarcinoma, and initial staging CTs were retrospectively identified from institutional clinic encounters between 2000 and 2019. Details about patient, disease, treatment, and outcomes (including therapy tolerance and survival) were extracted from electronic medical records. A deep learning semantic segmentation algorithm was utilized to measure cross-sectional areas of skeletal muscle (SM), visceral fat (VF), and subcutaneous fat (SF) at the L3 vertebra level on staging CTs. Univariate and multivariate analyses were performed to assess the relationships between predictors and outcomes.

RESULTS: 142 patients were evaluated. Median survival was 52 months. Univariate and multivariate analysis showed significant associations between treatment tolerance and SM and VF area, SM to fat and VF to SF ratios, and skeletal muscle index (SMI) (p = 0.004-0.04). Increased survival was associated with increased body mass index (BMI) (p = 0.01) and increased SMI (p = 0.004). A multivariate Cox model consisting of BMI, SMI, age, gender, and stage demonstrated that patients in the high-risk group had significantly lower survival (HR = 1.77, 95% CI = 1.13-2.78, p = 0.008).

CONCLUSION: CT-based measures of body composition in patients with gastroesophageal adenocarcinoma may be independent predictors of treatment complications and survival and can supplement methods for assessing functional status during treatment planning.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. DeFreitas, Toronka, Nedrud, et al. CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma. Abdom Radiol (NY). 2022. PMID: 36209446. doi:10.1007/s00261-022-03695-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。